SlideShare une entreprise Scribd logo
1  sur  5
Télécharger pour lire hors ligne
Dheeravath Saida Naik et al Int. Journal of Engineering Research and Application
ISSN : 2248-9622, Vol. 3, Issue 6, Nov-Dec 2013, pp.01-05

RESEARCH ARTICLE

www.ijera.com

OPEN ACCESS

Method Develop and Validation of Eletriptan Hydrobromide
Pharmaceutical Dosage Form By Rp-Hplc
Dheeravath Saida Naik*, Kasani Ramadevi, Bhagawan.D
33-84, Edukotla Thanda, Miryalguda, Nalgonda Andhrapradesh-508207.
Abstract
A reverse phase high performance liquid chromatographic method has been described for the estimation of
Eletriptan Hydrobromide in its pharmaceutical dosage forms using symmetry C18 (4.6×100nm, 3.5μm) column.
In isocratic mode using phosphate buffer: Acetonitrile ratio of 60:40 v/v. The detection was carried out using
UV detector at 221 nm. The linearity of Eletriptan Hydrobromide was found to be in the concentration range of
10 to 50 μg/ ml. The flow rate was 0.9 ml/min and the run time was 6 min. The Eletriptan Hydrobromide
retention time was observed to be 2.29min .The developed method was validated with respect to linearity,
precision, accuracy and specificity as per the International Conference on Harmonisation (ICH) guidelines. The
mean recoveries were found to be within the limits. The developed method was simple, fast, accurate and
precise and has been successfully applied for the analysis of Eletriptan Hydrobromide in bulk sample and in
pharmaceutical dosage forms.
Keywords: Eletriptan Hydrobromide, Phosphate Buffer, Acetonitrile, Retention Time, linearity

I.

INTRODUCTION

Eletriptan,
3-((R)-1-methyl-2-pyrrolidinyl)
Methyl)-5-_2-(phenylsulfonyl)
ethyl-indole
hydrobromide (Fig. 1), is a new orally active 5-HT
1B/1D agonist, recently approved by the Food and
Drug Administration for the acute treatment of
migraine headache.

Figure 1 Eletriptan Hydrobromide
Eletriptan Hydrobromide is believed to
reduce swelling of the blood vessels surrounding the
brain. This swelling is associated with the head pain of
a migraine attack. Eletriptan Hydrobromide blocks the
release of substance from nerve endings that cause
more pain and other symptoms like nausea, and
sensitivity to light and sound. It is thought that these
actions contribute to relief of symptoms by Eletriptan
Hydrobromide. A simple and accurate reverse phase
liquid chromatographic and UV-VIS methods are
developed for the determination (1, 8) of Eletriptan
hydrobromide.
Pharmaceutical analysis includes both
qualitative and quantitative analysis of drugs and
pharmaceutical substances starts from bulk drugs to
the finished dosage forms. Most frequently used
methods for quality analysis are UV spectroscopy,
FTIR and liquid chromatography and Mass
www.ijera.com

spectroscopy etc. Among them High performance
liquid chromatography is basically a highly improved
form of column chromatography. Instead of a solvent
being allowed to drip through a column under gravity,
it is forced through under high pressures of up to 400
atmospheres (2,4). That makes it much faster. It also
allows you to use a very much smaller particle size for
the column packing material which gives a much
greater surface area for interactions between the
stationary phase and the molecules flowing past it.
The chemical interaction of the stationary phase and
the sample within the mobile phase determines the
degree of migration and separation of the components
contained in the sample is the basic principle for High
performance liquid chromatography (HPCL) (3,9).
RP-HPLC operates on the principle of hydrophobic
interactions, which originates from the high symmetry
in the dipolar water structure and plays the most
important role in all processes in life science. RPHPLC allows the measurement of these interactive
forces. The binding of the analyte to the stationary
phase is proportional to the contact surface area
around the non-polar segment of the analyte molecule
upon association with the ligand on the stationary
phase. The validation criteria were given in Table -1.
Table-1: Criteria for Validation of the Method
ACCEPTA
CHARACTE
BLE
RISTICS
RANGE
Recovery
Accuracy
(98-102%)
Precision,
RSD < 2%
Intermediate
RSD < 2%
precision
Specificity
No
1|P age
Dheeravath Saida Naik et al Int. Journal of Engineering Research and Application
ISSN : 2248-9622, Vol. 3, Issue 6, Nov-Dec 2013, pp.01-05
LOD
LOQ
Linearity
Range
Stability

Interference
S/N > 2 or 3
S/N > 10
Correlation
Coefficient(
r)>0.99
80-120%
>24h or
>12h

www.ijera.com

However, the best of our knowledge there is
no available analytical method for Eletriptan
hydrobromide, for its elution within a short duration.
The aim of the present work is to develop a specific,
precise, accurate and rapid method to elute the
Eletriptan hydrobromide in short span of time.

II.

MATERIAL AND METHODS

The Chemicals/ Reagents, Solvents and
instruments used are given in below table- 2 and 3

Table-2: Shows Chemicals and Reagents
S. No.

Chemicals/standards and reagents

Grade

Make

1

Potassium dihydrogen phosphate

HPLC

Fisher

2

Ortho phosphoric acid

HPLC

Fisher

3

HPLC Grade Methanol

HPLC

Merck

HPLC Grade Acetonitrile

HPLC

Merck

Double Distilled Water

HPLC

Merck

Eletriptan Hydrobromide

N/A

4
5
6

Eletriptan Hydrobromide is a serotonin
agonist, specifically, it is a selective
5hydroxytryptamine 1B/1D(5-HT1B) receptor agonist.
Eletriptan Hydrobromide binds with high affinity to
the 5-HT1B,1D,1F receptors. It has a modest affinity
to the 5-HT1A,1E,3B,7 receptors(12)
Physical Properties:
Mol.Mass
Melting Point
PKa
acid -17.11

:

III.

RESULTS AND DISCUSSION:

UV spectrum was recorded for Eletriptan
Hydrobromide individually and the Lambda max of
Eletriptan Hydrobromide was found to be 215 nm.
UV-VIS spectrogram of Eletriptan Hydrobromide has
shown in fig- 2. It was found that Eletriptan
Hydrobromide can effectively be analyzed by using
the RP- HPLC method (4, 11).

:
382.52 g/mol
169-171°C
:
Strongest
Strongest base -

8.37
Water Solubility

S.No
.

1

2
3
4
5

:

Soluble

Table- 3: Shows Instruments and Equipments
Instruments
Softwar
and
Model
Company
e
Equipments
N 2000
Waters
chromat 515pump
HPLC
o
,
WATERS
graphic
Detector
system
2487
UVUV
UVTECHCO
Spectrophotome
Analyst
2310
MP
ter
Weighing
SHIMADZ
N/A
XEX 200
Balance
U
ENERTEC
Sonicator
N/A
SE60US
H
pH Meter
N/A
AD102U
ADWA

www.ijera.com

Fig 2: UV-VIS spectrum and accuracy assessment
of Eletriptan hydrobromide

2|P age
Dheeravath Saida Naik et al Int. Journal of Engineering Research and Application
ISSN : 2248-9622, Vol. 3, Issue 6, Nov-Dec 2013, pp.01-05
Table-4: Accuracy Observation of Eletriptan Hydrobromide
% Concentration
Amount
Amount
(at specification
Area
Added
Found
Level)
(mcg)
(mcg)

% Recovery

50 %

1982240

15.0

14.98

2594119

30.0

30.59

101.96

150 %

3269320

45.0

45.86

Mean
Recovery

99.89

100 %

www.ijera.com

101.91

The accuracy studies were shown as %
recovery for Eletriptan Hydrobromide at 50 %, 100 %
and 150 %( Table-4) the limits of % recovered should

101.96

be in the range of 98-102 %. The results obtained for
Eletriptan Hydrobromide were found to be within the
limits. Hence the method was found to be accurate
(fig-3)

Fig 3: Precision and linearity of the Eletriptan at deferent dosages
Table-5: Observation of System Precision
ELETRIPTAN
INJECTION
HYDROBROMIDE
AREA
Injection1
2977138
Injection2
2917756
Injection3
2861139
Injection4
2922541
Injection5
2908272
Average
Standard
Deviation
% RSD

the same homogenous sample under prescribed
conditions. In this study 5 replicate injections of
Eletriptan Hydrobromide formulation (method
precision) was performed %RSD was determined for
peak areas (Table-5). The acceptance limit should be
not more than 2 % and the results were obtained for
standard samples (method precision) were found to be
within the acceptance limits (6).

2917369
41363.63
1.41784

The precision of an analytical procedure
expresses the closeness of agreement among a series
of measurements obtained from multiple samplings of
www.ijera.com

3|P age
Dheeravath Saida Naik et al Int. Journal of Engineering Research and Application
ISSN : 2248-9622, Vol. 3, Issue 6, Nov-Dec 2013, pp.01-05
Table-6: Observation of Intermediate System
Precision
ELETRIPTAN
Injection
HYDROBROMIDE
Area
Injection1
3045134
Injection2
Injection3
Injection4
Injection5
Mean
Standard Deviation
% RSD

2

0.8
0.9

3

2516
2549

1.0

2335

Table-9: Summarized RP-HPLC Method for
Eletriptan Hydrobromide

1

For Intermediate precision studies 5 replicate
injections (Table-6) formulation (method id precision)
was performed. % RSD was determined for peak areas
of sample of ELETRIPTAN HYDROBROMIDE. The
acceptance limit are should be not more than 2 % and
the results were obtained for sample (method ID
precision)were found to be within the acceptance
limits.
The linearity of an analytical procedure is its
ability (within a given range) to obtain test results,
which are directly proportional to the concentration of
the analyte in the sample represented in fig-3 (10).
The linearity range was found to be 10-50 µg/ml for
Eletriptan Hydrobromide. Calibration curve was
plotted and correlation co-efficient for all the drugs
are found to be 0.999. Hence the results obtained were
within the acceptable limits.
Table-7: Flow rate observation of Eletriptan
Hydrobromide
System Suitability Results
Flow Rate
USP Plate
S.No
USP Tailing
(ml/min)
Count
1

The system suitability Parameters were found
to be within the specified limits (Table-8) for the
proposed method.

S.No

3042317
3041284
3047977
3056220
3046586.4
5983.15772
0.196388907

1.3
1.3
1.3

* Results for actual flow (ml/min) have been
considered from Assay standard
Table-8: Observation of System Suitability
Parameters
ELETRIPTAN
S. No
Parameter
HYDROBROMIDE
1

Retention time

2.3

2

Theoretical plates

2549.0

3

Tailing factor

1.3

4

Area

www.ijera.com

Parameter

System
suitability

Acceptance
criteria
Theoretical
PlatesNLT2000
Tailing factorNMT 2
ResolutionNLT 2

2

Precision

% RSD

3

ID
Precision

% RSD

4

Linearity

5

Accuracy

6
7

LOD
LOQ

Results
2549
1.3
0.0
1.41
0.19

Correlation
coefficient
0.9990
NLT 0.999
Percentage
Recovery
101.96
98-102%
0.19ug/ml
0.64ug/ml

The limit of detection (LOD) represents the
concentration of analyte. The limit of detection for the
Eletriptan hydrobromide was found to be 0.19 μg ml-1
for 10 μl (Table-9) of injection volume. The LOQ
represents the concentration of analyte that would
yield a signal-to-noise ratio of 10 (fig-3). The limit of
quantitation for the S-isomer was found to be 0.64 μg
ml-1 for the 10 μl of injection volume (5).
The ruggedness of a method was defined as
degree of reproducibility of results obtained by
analysis of the same sample under a variety of normal
test conditions such as different laboratories, different
analysts, different instruments and different days(7).
The robustness of an analytical procedure is
measured by its capability to remain unaffected
through small, but deliberate, variations in method
parameters and provide an indication of its reliability
during normal usage. In the varied chromatographic
conditions like flow rate was found to be >2.0
illustrating the robustness of the method. The results
are summarized on evaluation of the above results, it
can be concluded that the variation in flow rate
affected the method significantly (table-7). Hence it
indicates that the method is robust even by change in
the flow rate ±10 %.
The method is robust only in less flow
condition.

3040909

www.ijera.com

4|P age
Dheeravath Saida Naik et al Int. Journal of Engineering Research and Application
ISSN : 2248-9622, Vol. 3, Issue 6, Nov-Dec 2013, pp.01-05
IV.






CONCLUSION

The evaluation of obtained values suggests that
the proposed HPLC methods provide simple,
precise, rapid and robust quantitative analytical
method
for
estimation
of
Eletriptan
HydroBromide in pharmaceutical dosage form.
The mobile phase is simple to prepare and
economical.
As I validated method as per ICH guidelines and
correlating obtained values with the standard
values, satisfactory results were obtained.
Hence, the method can be easily and conveniently
adopted for routine estimation of Eletriptan
HydroBromide in pharmaceutical dosage form.

[9]

[10]

[11]

REFFERENCES
[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

Sharma B. K. Instrumental Method of
Chemical
Analysis.
23rdEdn.
Goal
publication house, 1991;7.
K.D.Tripathi . Essentials of medical
pharmacology fifth edition. Jaypee brothers
medical publishers(p) Ltd, New Delhi, 139 143.
Arnold R. Martin,Wilson and Griswold’s text
book
of
organic
medicinal
and
pharmaceutical chemistry, 8thEdn., Lippincott
Williams &wilkins. 1998; 423 - 424
Sethi P.D. HPLC ‘High Performance Liquid
Chromatography’. Quantitative Analysis of
Pharmaceutical Formulations,1stEdn., CBS
Publishers and Distributors, New Delhi.
2001; 3.
Mirazecvic, Biljanajoic. Validation of an hplc
method for the simultaneous determination of
eletriptan hydrobromide.
UK 120.413,
j.serb.chem Soc. 71 (11), 2006; 1195–1205.
M. Sarat, P. Murali Krishna and C. Rambabu,
A Validated LC method for the determination
of chiral purity of (r)-3-((1-methylpyrrolidin2-yl) methyl)-5-(methylsulfonylmethyl)-1hindole:
a
key
raw
material
of
elitriptanhydrobromide, International journal
of pharmaceutical science and research,
2012, p. 3151-3155.
P. Sunitha, CH. Jhansirani, B. Kavitha, N.
Sirisha and A. Pavani, 2012, Method
Development
And
Validation
of
ELETRIPTAN
HYDROBROMIDEHydrobromide Tablets
By Uv-VisibleSpectrophotometric Method,
International Journal Of Pharmaceutical,
Chemical And Biological Sciences, IJPCBS,
2012, 2(4), 427-430.
N. Balaji, V.R. Sivaraman, Dr.P. Neeraja. A
validated
UPLC
method
for
the
determination of processrelated impurities in
Antimigraine bulk drug, IOSR Journal of
Applied Chemistry (IOSR-JAC), 2013, PP
20-28.

www.ijera.com

[12]

www.ijera.com

Ramzia I. El-Bagary, Nashwah G.
Mohammed, and Heba A. Nasr. 2012. Two
Chromatographic
Methods
for
the
Determination of Some Antimigraine Drugs,
analytical chemistry insights, Anal Chem
Insights. 2012, 7: 13–21.
MilkicaCrevar-Sakač,
ZoricaVujić,
JasminaBrborić,
VesnaKuntić
and
SnežanaUskoković-Marković, 2013,
An
Improved HPLC Method with the Aid of a
Chemometric
Protocol:
Simultaneous
Determination of Atorvastatin and Its
Metabolites in Plasma, Molecules, 2013, 18,
2469-2482
Sethi P.D. HPLC ‘High Performance Liquid
Chromatography’, Quantitative Analysis of
Pharmaceutical Formulations,1st Edn., CBS
Publishers and Distributors, New Delhi,
2001, 60.
United States Pharmacopoeia, NF 21, Asian
Edn.,
United
States
Pharmacopoeial
Convention, Inc. Web com Ltd., 2003, 2278.

5|P age

Contenu connexe

Tendances

Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...pharmaindexing
 
Case Study: Nylon Syringe Filter E&L
Case Study: Nylon Syringe Filter E&LCase Study: Nylon Syringe Filter E&L
Case Study: Nylon Syringe Filter E&LJordi Labs
 
Estimation of olopatadine hydrochloride by RP–HPLC and U.V spectrophotometry ...
Estimation of olopatadine hydrochloride by RP–HPLC and U.V spectrophotometry ...Estimation of olopatadine hydrochloride by RP–HPLC and U.V spectrophotometry ...
Estimation of olopatadine hydrochloride by RP–HPLC and U.V spectrophotometry ...pharmaindexing
 
Multiple Method Development and Validation for Simultaneous Estimation of Chl...
Multiple Method Development and Validation for Simultaneous Estimation of Chl...Multiple Method Development and Validation for Simultaneous Estimation of Chl...
Multiple Method Development and Validation for Simultaneous Estimation of Chl...ijtsrd
 
Development and Validation of the HPLC Method for the Analysis of Ametridio...
	 Development and Validation of the HPLC Method for the Analysis of Ametridio...	 Development and Validation of the HPLC Method for the Analysis of Ametridio...
Development and Validation of the HPLC Method for the Analysis of Ametridio...iosrphr_editor
 
Analysis of “The Big Four” Heavy Metals in Hops by Graphite Furnace Atomic Ab...
Analysis of “The Big Four” Heavy Metals in Hops by Graphite Furnace Atomic Ab...Analysis of “The Big Four” Heavy Metals in Hops by Graphite Furnace Atomic Ab...
Analysis of “The Big Four” Heavy Metals in Hops by Graphite Furnace Atomic Ab...Shimadzu Scientific Instruments
 
Development and validation of HPLC method for the estimation of Escitalopram ...
Development and validation of HPLC method for the estimation of Escitalopram ...Development and validation of HPLC method for the estimation of Escitalopram ...
Development and validation of HPLC method for the estimation of Escitalopram ...SriramNagarajan15
 
method development and validation
method development and validationmethod development and validation
method development and validationNITIN KANWALE
 
Analytical method development and validation for the estimation of Nimesulide...
Analytical method development and validation for the estimation of Nimesulide...Analytical method development and validation for the estimation of Nimesulide...
Analytical method development and validation for the estimation of Nimesulide...SriramNagarajan18
 
TRIBESTAN AUSTRALIAN study
TRIBESTAN AUSTRALIAN studyTRIBESTAN AUSTRALIAN study
TRIBESTAN AUSTRALIAN studyGeorgi Daskalov
 
GC Analysis of Residual Solvents in Pharmaceuticals (USP&lt;467>)
GC Analysis of Residual Solvents in Pharmaceuticals (USP&lt;467>)GC Analysis of Residual Solvents in Pharmaceuticals (USP&lt;467>)
GC Analysis of Residual Solvents in Pharmaceuticals (USP&lt;467>)Shimadzu Scientific Instruments
 
Recent advancement in impurity profiling
Recent advancement in impurity profilingRecent advancement in impurity profiling
Recent advancement in impurity profilingPiramal Healthcare
 
MALDI-TOF MS Based Discovery Workflows: A Fully Automated, Bottom-Up Approach
MALDI-TOF MS Based Discovery Workflows: A Fully Automated, Bottom-Up ApproachMALDI-TOF MS Based Discovery Workflows: A Fully Automated, Bottom-Up Approach
MALDI-TOF MS Based Discovery Workflows: A Fully Automated, Bottom-Up ApproachShimadzu Scientific Instruments
 
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLCSimultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLCpharmaindexing
 
Analytical method development and validation for simultaneous estimation of n...
Analytical method development and validation for simultaneous estimation of n...Analytical method development and validation for simultaneous estimation of n...
Analytical method development and validation for simultaneous estimation of n...pharmaindexing
 
Polymer Deformulation of a Medical Device case study
Polymer Deformulation of a Medical Device case studyPolymer Deformulation of a Medical Device case study
Polymer Deformulation of a Medical Device case studyJordi Labs
 
LCMS-MS Method for Evaluation of PPCPs in Environmental Water
LCMS-MS Method for Evaluation of PPCPs in Environmental WaterLCMS-MS Method for Evaluation of PPCPs in Environmental Water
LCMS-MS Method for Evaluation of PPCPs in Environmental WaterShimadzu Scientific Instruments
 

Tendances (20)

Love ppt
Love pptLove ppt
Love ppt
 
HPLC Method Development
HPLC Method DevelopmentHPLC Method Development
HPLC Method Development
 
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
 
Case Study: Nylon Syringe Filter E&L
Case Study: Nylon Syringe Filter E&LCase Study: Nylon Syringe Filter E&L
Case Study: Nylon Syringe Filter E&L
 
Estimation of olopatadine hydrochloride by RP–HPLC and U.V spectrophotometry ...
Estimation of olopatadine hydrochloride by RP–HPLC and U.V spectrophotometry ...Estimation of olopatadine hydrochloride by RP–HPLC and U.V spectrophotometry ...
Estimation of olopatadine hydrochloride by RP–HPLC and U.V spectrophotometry ...
 
Multiple Method Development and Validation for Simultaneous Estimation of Chl...
Multiple Method Development and Validation for Simultaneous Estimation of Chl...Multiple Method Development and Validation for Simultaneous Estimation of Chl...
Multiple Method Development and Validation for Simultaneous Estimation of Chl...
 
Development and Validation of the HPLC Method for the Analysis of Ametridio...
	 Development and Validation of the HPLC Method for the Analysis of Ametridio...	 Development and Validation of the HPLC Method for the Analysis of Ametridio...
Development and Validation of the HPLC Method for the Analysis of Ametridio...
 
Analysis of “The Big Four” Heavy Metals in Hops by Graphite Furnace Atomic Ab...
Analysis of “The Big Four” Heavy Metals in Hops by Graphite Furnace Atomic Ab...Analysis of “The Big Four” Heavy Metals in Hops by Graphite Furnace Atomic Ab...
Analysis of “The Big Four” Heavy Metals in Hops by Graphite Furnace Atomic Ab...
 
Development and validation of HPLC method for the estimation of Escitalopram ...
Development and validation of HPLC method for the estimation of Escitalopram ...Development and validation of HPLC method for the estimation of Escitalopram ...
Development and validation of HPLC method for the estimation of Escitalopram ...
 
Gas chromatography
Gas chromatographyGas chromatography
Gas chromatography
 
method development and validation
method development and validationmethod development and validation
method development and validation
 
Analytical method development and validation for the estimation of Nimesulide...
Analytical method development and validation for the estimation of Nimesulide...Analytical method development and validation for the estimation of Nimesulide...
Analytical method development and validation for the estimation of Nimesulide...
 
TRIBESTAN AUSTRALIAN study
TRIBESTAN AUSTRALIAN studyTRIBESTAN AUSTRALIAN study
TRIBESTAN AUSTRALIAN study
 
GC Analysis of Residual Solvents in Pharmaceuticals (USP&lt;467>)
GC Analysis of Residual Solvents in Pharmaceuticals (USP&lt;467>)GC Analysis of Residual Solvents in Pharmaceuticals (USP&lt;467>)
GC Analysis of Residual Solvents in Pharmaceuticals (USP&lt;467>)
 
Recent advancement in impurity profiling
Recent advancement in impurity profilingRecent advancement in impurity profiling
Recent advancement in impurity profiling
 
MALDI-TOF MS Based Discovery Workflows: A Fully Automated, Bottom-Up Approach
MALDI-TOF MS Based Discovery Workflows: A Fully Automated, Bottom-Up ApproachMALDI-TOF MS Based Discovery Workflows: A Fully Automated, Bottom-Up Approach
MALDI-TOF MS Based Discovery Workflows: A Fully Automated, Bottom-Up Approach
 
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLCSimultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
 
Analytical method development and validation for simultaneous estimation of n...
Analytical method development and validation for simultaneous estimation of n...Analytical method development and validation for simultaneous estimation of n...
Analytical method development and validation for simultaneous estimation of n...
 
Polymer Deformulation of a Medical Device case study
Polymer Deformulation of a Medical Device case studyPolymer Deformulation of a Medical Device case study
Polymer Deformulation of a Medical Device case study
 
LCMS-MS Method for Evaluation of PPCPs in Environmental Water
LCMS-MS Method for Evaluation of PPCPs in Environmental WaterLCMS-MS Method for Evaluation of PPCPs in Environmental Water
LCMS-MS Method for Evaluation of PPCPs in Environmental Water
 

En vedette (20)

Lk3519521955
Lk3519521955Lk3519521955
Lk3519521955
 
Lf3519191924
Lf3519191924Lf3519191924
Lf3519191924
 
Di36654660
Di36654660Di36654660
Di36654660
 
Lr3519932004
Lr3519932004Lr3519932004
Lr3519932004
 
Lv3520212024
Lv3520212024Lv3520212024
Lv3520212024
 
Ae36176187
Ae36176187Ae36176187
Ae36176187
 
As36269275
As36269275As36269275
As36269275
 
Bo36390397
Bo36390397Bo36390397
Bo36390397
 
Bi36358362
Bi36358362Bi36358362
Bi36358362
 
Bf36342346
Bf36342346Bf36342346
Bf36342346
 
Ac36167172
Ac36167172Ac36167172
Ac36167172
 
Ad36173175
Ad36173175Ad36173175
Ad36173175
 
Aa36155160
Aa36155160Aa36155160
Aa36155160
 
Scala #5
Scala #5Scala #5
Scala #5
 
Group 6 final 3
Group 6   final 3Group 6   final 3
Group 6 final 3
 
Pecha kucha
Pecha kuchaPecha kucha
Pecha kucha
 
[A31]AWS上でOracleを利用するためのはじめの一歩!by Masatoshi Yoshida
[A31]AWS上でOracleを利用するためのはじめの一歩!by Masatoshi Yoshida[A31]AWS上でOracleを利用するためのはじめの一歩!by Masatoshi Yoshida
[A31]AWS上でOracleを利用するためのはじめの一歩!by Masatoshi Yoshida
 
Tecnologia ethernet
Tecnologia ethernetTecnologia ethernet
Tecnologia ethernet
 
Rev hendu
Rev henduRev hendu
Rev hendu
 
Motivação
MotivaçãoMotivação
Motivação
 

Similaire à A360105

Simultaneous estimation of amitryptyline and chlordiazepoxide by RP-HPLC method
Simultaneous estimation of amitryptyline and chlordiazepoxide by RP-HPLC methodSimultaneous estimation of amitryptyline and chlordiazepoxide by RP-HPLC method
Simultaneous estimation of amitryptyline and chlordiazepoxide by RP-HPLC methodpharmaindexing
 
Quality-by-design-based development and validation of a stability-indicating ...
Quality-by-design-based development and validation of a stability-indicating ...Quality-by-design-based development and validation of a stability-indicating ...
Quality-by-design-based development and validation of a stability-indicating ...Ratnakaram Venkata Nadh
 
Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...pharmaindexing
 
RP-HPLC method development and validation for the analyisis of dronedarone hy...
RP-HPLC method development and validation for the analyisis of dronedarone hy...RP-HPLC method development and validation for the analyisis of dronedarone hy...
RP-HPLC method development and validation for the analyisis of dronedarone hy...SriramNagarajan17
 
UV Spectrophotometeric Analytical Method Development and Validation for the D...
UV Spectrophotometeric Analytical Method Development and Validation for the D...UV Spectrophotometeric Analytical Method Development and Validation for the D...
UV Spectrophotometeric Analytical Method Development and Validation for the D...ijtsrd
 
Analysis Of Steroids
Analysis Of SteroidsAnalysis Of Steroids
Analysis Of SteroidsJackie Taylor
 
Analytical Method Development and Validation for the Estimation of Zolmitript...
Analytical Method Development and Validation for the Estimation of Zolmitript...Analytical Method Development and Validation for the Estimation of Zolmitript...
Analytical Method Development and Validation for the Estimation of Zolmitript...ijtsrd
 
Stability indicating method development and validation for the estimation of ...
Stability indicating method development and validation for the estimation of ...Stability indicating method development and validation for the estimation of ...
Stability indicating method development and validation for the estimation of ...SriramNagarajan18
 
zidovudine hplc method
zidovudine hplc method zidovudine hplc method
zidovudine hplc method Aparna Rajeevi
 
full length work ppt.ppt
full length work ppt.pptfull length work ppt.ppt
full length work ppt.ppthamidpasha6
 
A new analytical method development and validation for the simultaneus estima...
A new analytical method development and validation for the simultaneus estima...A new analytical method development and validation for the simultaneus estima...
A new analytical method development and validation for the simultaneus estima...SriramNagarajan19
 
Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy
 Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy
Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacysaathiyaa
 
Determination of Etodolac in Commercial Formulations by HPLC-UV Method
Determination of Etodolac in Commercial Formulations by HPLC-UV MethodDetermination of Etodolac in Commercial Formulations by HPLC-UV Method
Determination of Etodolac in Commercial Formulations by HPLC-UV Methodijtsrd
 
Spectrophotometric Determination of Cardiovascular Drugs
Spectrophotometric Determination of Cardiovascular DrugsSpectrophotometric Determination of Cardiovascular Drugs
Spectrophotometric Determination of Cardiovascular DrugsIJMER
 
UV-vis. spectroscopy N HPLC (rilpivirine) by RJcharan.
UV-vis. spectroscopy N HPLC (rilpivirine) by RJcharan.UV-vis. spectroscopy N HPLC (rilpivirine) by RJcharan.
UV-vis. spectroscopy N HPLC (rilpivirine) by RJcharan.RJ Charan
 
Spectrophotometric Estimation of Dronedarone Hydrochloride in Pharmaceutical ...
Spectrophotometric Estimation of Dronedarone Hydrochloride in Pharmaceutical ...Spectrophotometric Estimation of Dronedarone Hydrochloride in Pharmaceutical ...
Spectrophotometric Estimation of Dronedarone Hydrochloride in Pharmaceutical ...Jing Zang
 
Stability indicating method development and validation for the simultaneous e...
Stability indicating method development and validation for the simultaneous e...Stability indicating method development and validation for the simultaneous e...
Stability indicating method development and validation for the simultaneous e...pharmaindexing
 
“Analytical Method Development and Validation of Simultaneous Estimation of A...
“Analytical Method Development and Validation of Simultaneous Estimation of A...“Analytical Method Development and Validation of Simultaneous Estimation of A...
“Analytical Method Development and Validation of Simultaneous Estimation of A...IRJET Journal
 
Method Development and Validation for Simultaneous estimation of Metformin Hc...
Method Development and Validation for Simultaneous estimation of Metformin Hc...Method Development and Validation for Simultaneous estimation of Metformin Hc...
Method Development and Validation for Simultaneous estimation of Metformin Hc...pharmaindexing
 

Similaire à A360105 (20)

Simultaneous estimation of amitryptyline and chlordiazepoxide by RP-HPLC method
Simultaneous estimation of amitryptyline and chlordiazepoxide by RP-HPLC methodSimultaneous estimation of amitryptyline and chlordiazepoxide by RP-HPLC method
Simultaneous estimation of amitryptyline and chlordiazepoxide by RP-HPLC method
 
Quality-by-design-based development and validation of a stability-indicating ...
Quality-by-design-based development and validation of a stability-indicating ...Quality-by-design-based development and validation of a stability-indicating ...
Quality-by-design-based development and validation of a stability-indicating ...
 
Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...Method development and validation for the estimation of metronidazole in tabl...
Method development and validation for the estimation of metronidazole in tabl...
 
RP-HPLC method development and validation for the analyisis of dronedarone hy...
RP-HPLC method development and validation for the analyisis of dronedarone hy...RP-HPLC method development and validation for the analyisis of dronedarone hy...
RP-HPLC method development and validation for the analyisis of dronedarone hy...
 
UV Spectrophotometeric Analytical Method Development and Validation for the D...
UV Spectrophotometeric Analytical Method Development and Validation for the D...UV Spectrophotometeric Analytical Method Development and Validation for the D...
UV Spectrophotometeric Analytical Method Development and Validation for the D...
 
Analysis Of Steroids
Analysis Of SteroidsAnalysis Of Steroids
Analysis Of Steroids
 
Analytical Method Development and Validation for the Estimation of Zolmitript...
Analytical Method Development and Validation for the Estimation of Zolmitript...Analytical Method Development and Validation for the Estimation of Zolmitript...
Analytical Method Development and Validation for the Estimation of Zolmitript...
 
Stability indicating method development and validation for the estimation of ...
Stability indicating method development and validation for the estimation of ...Stability indicating method development and validation for the estimation of ...
Stability indicating method development and validation for the estimation of ...
 
zidovudine hplc method
zidovudine hplc method zidovudine hplc method
zidovudine hplc method
 
full length work ppt.ppt
full length work ppt.pptfull length work ppt.ppt
full length work ppt.ppt
 
A new analytical method development and validation for the simultaneus estima...
A new analytical method development and validation for the simultaneus estima...A new analytical method development and validation for the simultaneus estima...
A new analytical method development and validation for the simultaneus estima...
 
Method development and validation
Method development and validationMethod development and validation
Method development and validation
 
Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy
 Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy
Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy
 
Determination of Etodolac in Commercial Formulations by HPLC-UV Method
Determination of Etodolac in Commercial Formulations by HPLC-UV MethodDetermination of Etodolac in Commercial Formulations by HPLC-UV Method
Determination of Etodolac in Commercial Formulations by HPLC-UV Method
 
Spectrophotometric Determination of Cardiovascular Drugs
Spectrophotometric Determination of Cardiovascular DrugsSpectrophotometric Determination of Cardiovascular Drugs
Spectrophotometric Determination of Cardiovascular Drugs
 
UV-vis. spectroscopy N HPLC (rilpivirine) by RJcharan.
UV-vis. spectroscopy N HPLC (rilpivirine) by RJcharan.UV-vis. spectroscopy N HPLC (rilpivirine) by RJcharan.
UV-vis. spectroscopy N HPLC (rilpivirine) by RJcharan.
 
Spectrophotometric Estimation of Dronedarone Hydrochloride in Pharmaceutical ...
Spectrophotometric Estimation of Dronedarone Hydrochloride in Pharmaceutical ...Spectrophotometric Estimation of Dronedarone Hydrochloride in Pharmaceutical ...
Spectrophotometric Estimation of Dronedarone Hydrochloride in Pharmaceutical ...
 
Stability indicating method development and validation for the simultaneous e...
Stability indicating method development and validation for the simultaneous e...Stability indicating method development and validation for the simultaneous e...
Stability indicating method development and validation for the simultaneous e...
 
“Analytical Method Development and Validation of Simultaneous Estimation of A...
“Analytical Method Development and Validation of Simultaneous Estimation of A...“Analytical Method Development and Validation of Simultaneous Estimation of A...
“Analytical Method Development and Validation of Simultaneous Estimation of A...
 
Method Development and Validation for Simultaneous estimation of Metformin Hc...
Method Development and Validation for Simultaneous estimation of Metformin Hc...Method Development and Validation for Simultaneous estimation of Metformin Hc...
Method Development and Validation for Simultaneous estimation of Metformin Hc...
 

Dernier

Building Your Own AI Instance (TBLC AI )
Building Your Own AI Instance (TBLC AI )Building Your Own AI Instance (TBLC AI )
Building Your Own AI Instance (TBLC AI )Brian Pichman
 
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDEADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDELiveplex
 
Empowering Africa's Next Generation: The AI Leadership Blueprint
Empowering Africa's Next Generation: The AI Leadership BlueprintEmpowering Africa's Next Generation: The AI Leadership Blueprint
Empowering Africa's Next Generation: The AI Leadership BlueprintMahmoud Rabie
 
9 Steps For Building Winning Founding Team
9 Steps For Building Winning Founding Team9 Steps For Building Winning Founding Team
9 Steps For Building Winning Founding TeamAdam Moalla
 
UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7DianaGray10
 
UiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPathCommunity
 
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdfIaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdfDaniel Santiago Silva Capera
 
Linked Data in Production: Moving Beyond Ontologies
Linked Data in Production: Moving Beyond OntologiesLinked Data in Production: Moving Beyond Ontologies
Linked Data in Production: Moving Beyond OntologiesDavid Newbury
 
AI Fame Rush Review – Virtual Influencer Creation In Just Minutes
AI Fame Rush Review – Virtual Influencer Creation In Just MinutesAI Fame Rush Review – Virtual Influencer Creation In Just Minutes
AI Fame Rush Review – Virtual Influencer Creation In Just MinutesMd Hossain Ali
 
AI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity WebinarAI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity WebinarPrecisely
 
Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1DianaGray10
 
Building AI-Driven Apps Using Semantic Kernel.pptx
Building AI-Driven Apps Using Semantic Kernel.pptxBuilding AI-Driven Apps Using Semantic Kernel.pptx
Building AI-Driven Apps Using Semantic Kernel.pptxUdaiappa Ramachandran
 
Bird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystemBird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystemAsko Soukka
 
Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024D Cloud Solutions
 
VoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBXVoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBXTarek Kalaji
 
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdf
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdf
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdfJamie (Taka) Wang
 
Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Adtran
 
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online CollaborationCOMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online Collaborationbruanjhuli
 
Computer 10: Lesson 10 - Online Crimes and Hazards
Computer 10: Lesson 10 - Online Crimes and HazardsComputer 10: Lesson 10 - Online Crimes and Hazards
Computer 10: Lesson 10 - Online Crimes and HazardsSeth Reyes
 

Dernier (20)

Building Your Own AI Instance (TBLC AI )
Building Your Own AI Instance (TBLC AI )Building Your Own AI Instance (TBLC AI )
Building Your Own AI Instance (TBLC AI )
 
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDEADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
 
Empowering Africa's Next Generation: The AI Leadership Blueprint
Empowering Africa's Next Generation: The AI Leadership BlueprintEmpowering Africa's Next Generation: The AI Leadership Blueprint
Empowering Africa's Next Generation: The AI Leadership Blueprint
 
9 Steps For Building Winning Founding Team
9 Steps For Building Winning Founding Team9 Steps For Building Winning Founding Team
9 Steps For Building Winning Founding Team
 
UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7
 
201610817 - edge part1
201610817 - edge part1201610817 - edge part1
201610817 - edge part1
 
UiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation Developers
 
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdfIaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
IaC & GitOps in a Nutshell - a FridayInANuthshell Episode.pdf
 
Linked Data in Production: Moving Beyond Ontologies
Linked Data in Production: Moving Beyond OntologiesLinked Data in Production: Moving Beyond Ontologies
Linked Data in Production: Moving Beyond Ontologies
 
AI Fame Rush Review – Virtual Influencer Creation In Just Minutes
AI Fame Rush Review – Virtual Influencer Creation In Just MinutesAI Fame Rush Review – Virtual Influencer Creation In Just Minutes
AI Fame Rush Review – Virtual Influencer Creation In Just Minutes
 
AI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity WebinarAI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity Webinar
 
Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1
 
Building AI-Driven Apps Using Semantic Kernel.pptx
Building AI-Driven Apps Using Semantic Kernel.pptxBuilding AI-Driven Apps Using Semantic Kernel.pptx
Building AI-Driven Apps Using Semantic Kernel.pptx
 
Bird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystemBird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystem
 
Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024
 
VoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBXVoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBX
 
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdf
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdf
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdf
 
Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™
 
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online CollaborationCOMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
 
Computer 10: Lesson 10 - Online Crimes and Hazards
Computer 10: Lesson 10 - Online Crimes and HazardsComputer 10: Lesson 10 - Online Crimes and Hazards
Computer 10: Lesson 10 - Online Crimes and Hazards
 

A360105

  • 1. Dheeravath Saida Naik et al Int. Journal of Engineering Research and Application ISSN : 2248-9622, Vol. 3, Issue 6, Nov-Dec 2013, pp.01-05 RESEARCH ARTICLE www.ijera.com OPEN ACCESS Method Develop and Validation of Eletriptan Hydrobromide Pharmaceutical Dosage Form By Rp-Hplc Dheeravath Saida Naik*, Kasani Ramadevi, Bhagawan.D 33-84, Edukotla Thanda, Miryalguda, Nalgonda Andhrapradesh-508207. Abstract A reverse phase high performance liquid chromatographic method has been described for the estimation of Eletriptan Hydrobromide in its pharmaceutical dosage forms using symmetry C18 (4.6×100nm, 3.5μm) column. In isocratic mode using phosphate buffer: Acetonitrile ratio of 60:40 v/v. The detection was carried out using UV detector at 221 nm. The linearity of Eletriptan Hydrobromide was found to be in the concentration range of 10 to 50 μg/ ml. The flow rate was 0.9 ml/min and the run time was 6 min. The Eletriptan Hydrobromide retention time was observed to be 2.29min .The developed method was validated with respect to linearity, precision, accuracy and specificity as per the International Conference on Harmonisation (ICH) guidelines. The mean recoveries were found to be within the limits. The developed method was simple, fast, accurate and precise and has been successfully applied for the analysis of Eletriptan Hydrobromide in bulk sample and in pharmaceutical dosage forms. Keywords: Eletriptan Hydrobromide, Phosphate Buffer, Acetonitrile, Retention Time, linearity I. INTRODUCTION Eletriptan, 3-((R)-1-methyl-2-pyrrolidinyl) Methyl)-5-_2-(phenylsulfonyl) ethyl-indole hydrobromide (Fig. 1), is a new orally active 5-HT 1B/1D agonist, recently approved by the Food and Drug Administration for the acute treatment of migraine headache. Figure 1 Eletriptan Hydrobromide Eletriptan Hydrobromide is believed to reduce swelling of the blood vessels surrounding the brain. This swelling is associated with the head pain of a migraine attack. Eletriptan Hydrobromide blocks the release of substance from nerve endings that cause more pain and other symptoms like nausea, and sensitivity to light and sound. It is thought that these actions contribute to relief of symptoms by Eletriptan Hydrobromide. A simple and accurate reverse phase liquid chromatographic and UV-VIS methods are developed for the determination (1, 8) of Eletriptan hydrobromide. Pharmaceutical analysis includes both qualitative and quantitative analysis of drugs and pharmaceutical substances starts from bulk drugs to the finished dosage forms. Most frequently used methods for quality analysis are UV spectroscopy, FTIR and liquid chromatography and Mass www.ijera.com spectroscopy etc. Among them High performance liquid chromatography is basically a highly improved form of column chromatography. Instead of a solvent being allowed to drip through a column under gravity, it is forced through under high pressures of up to 400 atmospheres (2,4). That makes it much faster. It also allows you to use a very much smaller particle size for the column packing material which gives a much greater surface area for interactions between the stationary phase and the molecules flowing past it. The chemical interaction of the stationary phase and the sample within the mobile phase determines the degree of migration and separation of the components contained in the sample is the basic principle for High performance liquid chromatography (HPCL) (3,9). RP-HPLC operates on the principle of hydrophobic interactions, which originates from the high symmetry in the dipolar water structure and plays the most important role in all processes in life science. RPHPLC allows the measurement of these interactive forces. The binding of the analyte to the stationary phase is proportional to the contact surface area around the non-polar segment of the analyte molecule upon association with the ligand on the stationary phase. The validation criteria were given in Table -1. Table-1: Criteria for Validation of the Method ACCEPTA CHARACTE BLE RISTICS RANGE Recovery Accuracy (98-102%) Precision, RSD < 2% Intermediate RSD < 2% precision Specificity No 1|P age
  • 2. Dheeravath Saida Naik et al Int. Journal of Engineering Research and Application ISSN : 2248-9622, Vol. 3, Issue 6, Nov-Dec 2013, pp.01-05 LOD LOQ Linearity Range Stability Interference S/N > 2 or 3 S/N > 10 Correlation Coefficient( r)>0.99 80-120% >24h or >12h www.ijera.com However, the best of our knowledge there is no available analytical method for Eletriptan hydrobromide, for its elution within a short duration. The aim of the present work is to develop a specific, precise, accurate and rapid method to elute the Eletriptan hydrobromide in short span of time. II. MATERIAL AND METHODS The Chemicals/ Reagents, Solvents and instruments used are given in below table- 2 and 3 Table-2: Shows Chemicals and Reagents S. No. Chemicals/standards and reagents Grade Make 1 Potassium dihydrogen phosphate HPLC Fisher 2 Ortho phosphoric acid HPLC Fisher 3 HPLC Grade Methanol HPLC Merck HPLC Grade Acetonitrile HPLC Merck Double Distilled Water HPLC Merck Eletriptan Hydrobromide N/A 4 5 6 Eletriptan Hydrobromide is a serotonin agonist, specifically, it is a selective 5hydroxytryptamine 1B/1D(5-HT1B) receptor agonist. Eletriptan Hydrobromide binds with high affinity to the 5-HT1B,1D,1F receptors. It has a modest affinity to the 5-HT1A,1E,3B,7 receptors(12) Physical Properties: Mol.Mass Melting Point PKa acid -17.11 : III. RESULTS AND DISCUSSION: UV spectrum was recorded for Eletriptan Hydrobromide individually and the Lambda max of Eletriptan Hydrobromide was found to be 215 nm. UV-VIS spectrogram of Eletriptan Hydrobromide has shown in fig- 2. It was found that Eletriptan Hydrobromide can effectively be analyzed by using the RP- HPLC method (4, 11). : 382.52 g/mol 169-171°C : Strongest Strongest base - 8.37 Water Solubility S.No . 1 2 3 4 5 : Soluble Table- 3: Shows Instruments and Equipments Instruments Softwar and Model Company e Equipments N 2000 Waters chromat 515pump HPLC o , WATERS graphic Detector system 2487 UVUV UVTECHCO Spectrophotome Analyst 2310 MP ter Weighing SHIMADZ N/A XEX 200 Balance U ENERTEC Sonicator N/A SE60US H pH Meter N/A AD102U ADWA www.ijera.com Fig 2: UV-VIS spectrum and accuracy assessment of Eletriptan hydrobromide 2|P age
  • 3. Dheeravath Saida Naik et al Int. Journal of Engineering Research and Application ISSN : 2248-9622, Vol. 3, Issue 6, Nov-Dec 2013, pp.01-05 Table-4: Accuracy Observation of Eletriptan Hydrobromide % Concentration Amount Amount (at specification Area Added Found Level) (mcg) (mcg) % Recovery 50 % 1982240 15.0 14.98 2594119 30.0 30.59 101.96 150 % 3269320 45.0 45.86 Mean Recovery 99.89 100 % www.ijera.com 101.91 The accuracy studies were shown as % recovery for Eletriptan Hydrobromide at 50 %, 100 % and 150 %( Table-4) the limits of % recovered should 101.96 be in the range of 98-102 %. The results obtained for Eletriptan Hydrobromide were found to be within the limits. Hence the method was found to be accurate (fig-3) Fig 3: Precision and linearity of the Eletriptan at deferent dosages Table-5: Observation of System Precision ELETRIPTAN INJECTION HYDROBROMIDE AREA Injection1 2977138 Injection2 2917756 Injection3 2861139 Injection4 2922541 Injection5 2908272 Average Standard Deviation % RSD the same homogenous sample under prescribed conditions. In this study 5 replicate injections of Eletriptan Hydrobromide formulation (method precision) was performed %RSD was determined for peak areas (Table-5). The acceptance limit should be not more than 2 % and the results were obtained for standard samples (method precision) were found to be within the acceptance limits (6). 2917369 41363.63 1.41784 The precision of an analytical procedure expresses the closeness of agreement among a series of measurements obtained from multiple samplings of www.ijera.com 3|P age
  • 4. Dheeravath Saida Naik et al Int. Journal of Engineering Research and Application ISSN : 2248-9622, Vol. 3, Issue 6, Nov-Dec 2013, pp.01-05 Table-6: Observation of Intermediate System Precision ELETRIPTAN Injection HYDROBROMIDE Area Injection1 3045134 Injection2 Injection3 Injection4 Injection5 Mean Standard Deviation % RSD 2 0.8 0.9 3 2516 2549 1.0 2335 Table-9: Summarized RP-HPLC Method for Eletriptan Hydrobromide 1 For Intermediate precision studies 5 replicate injections (Table-6) formulation (method id precision) was performed. % RSD was determined for peak areas of sample of ELETRIPTAN HYDROBROMIDE. The acceptance limit are should be not more than 2 % and the results were obtained for sample (method ID precision)were found to be within the acceptance limits. The linearity of an analytical procedure is its ability (within a given range) to obtain test results, which are directly proportional to the concentration of the analyte in the sample represented in fig-3 (10). The linearity range was found to be 10-50 µg/ml for Eletriptan Hydrobromide. Calibration curve was plotted and correlation co-efficient for all the drugs are found to be 0.999. Hence the results obtained were within the acceptable limits. Table-7: Flow rate observation of Eletriptan Hydrobromide System Suitability Results Flow Rate USP Plate S.No USP Tailing (ml/min) Count 1 The system suitability Parameters were found to be within the specified limits (Table-8) for the proposed method. S.No 3042317 3041284 3047977 3056220 3046586.4 5983.15772 0.196388907 1.3 1.3 1.3 * Results for actual flow (ml/min) have been considered from Assay standard Table-8: Observation of System Suitability Parameters ELETRIPTAN S. No Parameter HYDROBROMIDE 1 Retention time 2.3 2 Theoretical plates 2549.0 3 Tailing factor 1.3 4 Area www.ijera.com Parameter System suitability Acceptance criteria Theoretical PlatesNLT2000 Tailing factorNMT 2 ResolutionNLT 2 2 Precision % RSD 3 ID Precision % RSD 4 Linearity 5 Accuracy 6 7 LOD LOQ Results 2549 1.3 0.0 1.41 0.19 Correlation coefficient 0.9990 NLT 0.999 Percentage Recovery 101.96 98-102% 0.19ug/ml 0.64ug/ml The limit of detection (LOD) represents the concentration of analyte. The limit of detection for the Eletriptan hydrobromide was found to be 0.19 μg ml-1 for 10 μl (Table-9) of injection volume. The LOQ represents the concentration of analyte that would yield a signal-to-noise ratio of 10 (fig-3). The limit of quantitation for the S-isomer was found to be 0.64 μg ml-1 for the 10 μl of injection volume (5). The ruggedness of a method was defined as degree of reproducibility of results obtained by analysis of the same sample under a variety of normal test conditions such as different laboratories, different analysts, different instruments and different days(7). The robustness of an analytical procedure is measured by its capability to remain unaffected through small, but deliberate, variations in method parameters and provide an indication of its reliability during normal usage. In the varied chromatographic conditions like flow rate was found to be >2.0 illustrating the robustness of the method. The results are summarized on evaluation of the above results, it can be concluded that the variation in flow rate affected the method significantly (table-7). Hence it indicates that the method is robust even by change in the flow rate ±10 %. The method is robust only in less flow condition. 3040909 www.ijera.com 4|P age
  • 5. Dheeravath Saida Naik et al Int. Journal of Engineering Research and Application ISSN : 2248-9622, Vol. 3, Issue 6, Nov-Dec 2013, pp.01-05 IV.     CONCLUSION The evaluation of obtained values suggests that the proposed HPLC methods provide simple, precise, rapid and robust quantitative analytical method for estimation of Eletriptan HydroBromide in pharmaceutical dosage form. The mobile phase is simple to prepare and economical. As I validated method as per ICH guidelines and correlating obtained values with the standard values, satisfactory results were obtained. Hence, the method can be easily and conveniently adopted for routine estimation of Eletriptan HydroBromide in pharmaceutical dosage form. [9] [10] [11] REFFERENCES [1] [2] [3] [4] [5] [6] [7] [8] Sharma B. K. Instrumental Method of Chemical Analysis. 23rdEdn. Goal publication house, 1991;7. K.D.Tripathi . Essentials of medical pharmacology fifth edition. Jaypee brothers medical publishers(p) Ltd, New Delhi, 139 143. Arnold R. Martin,Wilson and Griswold’s text book of organic medicinal and pharmaceutical chemistry, 8thEdn., Lippincott Williams &wilkins. 1998; 423 - 424 Sethi P.D. HPLC ‘High Performance Liquid Chromatography’. Quantitative Analysis of Pharmaceutical Formulations,1stEdn., CBS Publishers and Distributors, New Delhi. 2001; 3. Mirazecvic, Biljanajoic. Validation of an hplc method for the simultaneous determination of eletriptan hydrobromide. UK 120.413, j.serb.chem Soc. 71 (11), 2006; 1195–1205. M. Sarat, P. Murali Krishna and C. Rambabu, A Validated LC method for the determination of chiral purity of (r)-3-((1-methylpyrrolidin2-yl) methyl)-5-(methylsulfonylmethyl)-1hindole: a key raw material of elitriptanhydrobromide, International journal of pharmaceutical science and research, 2012, p. 3151-3155. P. Sunitha, CH. Jhansirani, B. Kavitha, N. Sirisha and A. Pavani, 2012, Method Development And Validation of ELETRIPTAN HYDROBROMIDEHydrobromide Tablets By Uv-VisibleSpectrophotometric Method, International Journal Of Pharmaceutical, Chemical And Biological Sciences, IJPCBS, 2012, 2(4), 427-430. N. Balaji, V.R. Sivaraman, Dr.P. Neeraja. A validated UPLC method for the determination of processrelated impurities in Antimigraine bulk drug, IOSR Journal of Applied Chemistry (IOSR-JAC), 2013, PP 20-28. www.ijera.com [12] www.ijera.com Ramzia I. El-Bagary, Nashwah G. Mohammed, and Heba A. Nasr. 2012. Two Chromatographic Methods for the Determination of Some Antimigraine Drugs, analytical chemistry insights, Anal Chem Insights. 2012, 7: 13–21. MilkicaCrevar-Sakač, ZoricaVujić, JasminaBrborić, VesnaKuntić and SnežanaUskoković-Marković, 2013, An Improved HPLC Method with the Aid of a Chemometric Protocol: Simultaneous Determination of Atorvastatin and Its Metabolites in Plasma, Molecules, 2013, 18, 2469-2482 Sethi P.D. HPLC ‘High Performance Liquid Chromatography’, Quantitative Analysis of Pharmaceutical Formulations,1st Edn., CBS Publishers and Distributors, New Delhi, 2001, 60. United States Pharmacopoeia, NF 21, Asian Edn., United States Pharmacopoeial Convention, Inc. Web com Ltd., 2003, 2278. 5|P age